European Association for the Study of Diabetes

09/10/2025

📢 European Association for the Study of Diabetes will host its first Immunology School for Endocrinology: Immunology in type 1 diabetes, bridging basic science and clinical impact.

The programme offers an in-depth refresher on in T1D, exploring novel diagnostics and therapeutic tools for endocrine and diabetes care.

Led by, EASD President, Prof. Chantal Mathieu and Prof. Julia Mader, the course will feature lectures, workshops, and practical sessions on:
✅ New immunology concepts in T1D
✅ Early detection and staging
✅ Disease-modifying therapies and beta-cell replacement

Eligibility: open to EASD Members who are medical doctors, clinical researchers, or pharmacists in endocrinology or diabetology. Priority will be given to members who earned their medical degrees within the last 20 years.

📅 26 - 27 March 2026 |📍 Vienna, Austria

Learn more and apply 👉 https://www.easd.org/education/meetings-and-courses/immunology-school/immunology-school-2026/

09/10/2025

👀 Today we join the global eye care community in raising awareness of avoidable blindness and vision loss. Diabetes and vision are deeply connected: Diabetic retinopathy is one of the world's leading causes of blindness, yet it is one of the most preventable if caught early.

The good news: with early screening and effective management of blood glucose, blood pressure, and lipid management, most vision loss can be avoided.

With diabetes rates continuing to rise globally, protecting sight is an essential part of comprehensive diabetes care.

Let’s protect sight and strengthen care this 👁️

08/10/2025

🛫Can people with diabetes safely pilot aeroplanes? What if they use CGM or automated insulin delivery?

👉💡 In this new Expert Insights episode, Prof. Julia Mader discusses how a current European research project is testing diabetes tech up in the air - and what it could mean for enabling people with diabetes doing their jobs as pilots and Air Traffic Control Officers. Stay tuned for the results that are to be published this month!

📺 Watch now on the EASD e-Learning platform: https://easd-elearning.eu/episode/344/Navigating-the-skies-with-Julia-Mader.html

08/10/2025

📢 Great opportunity for early-career researchers and clinicians working in diabetes!

The EASD Early Career Academy have launched the next round of their Mentorship Programme - a fantastic opportunity to connect with leading experts, receive personalised career guidance, and grow within the diabetes research community.

Programme Highlights:
✅ 1-year mentorship with approximately 5 meetings (virtual or in-person)
✅ Travel Support of up to €1,000 per year
📌 Open to: Early-career professionals (up to assistant professorship level or equivalent) who are EASD members, based in Europe and active in diabetes

💡If you’re looking to advance your career in diabetes research, don’t miss this!

🗓️ Apply by 3 November 2025, 12:00 CET

🔗👉 https://www.easd.org/academy/academy-activities/mentorship-programme.html

07/10/2025

🧠 Meet Prof. Claudia Cavelti-Weder (Universitätsspital Zürich), recipient of the 2019 EFSD Future Leaders Mentorship Programme for Clinical Diabetologists grant.

Her project, “Characterisation of human intestinal macrophages in metabolic disease - iMAC Study”, aims to better our understanding of the role of different aspects of immune cells in human metabolic disease with a special focus on the role of intestinal macrophages.

Through this work, Prof. Cavelti-Weder and her team have made several important advances:
✅ Single-cell transcriptomics of intestinal myeloid cells in obesity revealed transcriptional reprogramming, including reduced oxidative phosphorylation suggesting immune dampening in the gut and potentially explaining higher infection susceptibility in obesity.
✅ The SLIM trial investigates whether immune and hormonal gut changes are reversible after bariatric surgery and how different surgical approaches affect inflammation and microbiota.
✅ Early PBMC gene expression analysis after metabolic surgery identified rapid regulation of genes linked to insulin signalling, cytoskeletal structure, and NF-κB pathways, pointing to early biomarkers predicting long-term metabolic outcomes.

“Participating in the mentorship programme was a great experience that enabled me to connect with leading researchers in the field and become part of the EASD community. The funding came at a critical time in my career and helped me advance both scientifically and professionally.” - Prof. Cavelti-Weder reflects.

📖 Read the preprint to learn more: https://www.medrxiv.org/content/10.1101/2025.06.20.25329990v1
💡 Explore EFSD opportunities: https://www.europeandiabetesfoundation.org/programmes.html

The EFSD Future Leaders Mentorship Programme for Clinical Diabetologists is supported by an unrestricted educational grant from AstraZeneca.

07/10/2025

🗣️ Have your say! The committee are requesting your input before it is finalised.

At this years, Annual Meeting, Prof. Richard Holt and Prof. Anne Peters presented an overview of the updated European Association for the Study of Diabetes - American Diabetes Association draft consensus report on the management of type 1 diabetes in adults, with:
✅ Revisions to diagnostic criteria
✅ Recommendations on diabetes technology, and
✅ Strategies for addressing obesity.

📅 The public commentary period is in progress and will close on 16 October 2025 at 23:59 ET.

If you would like to review the report and give your feedback please scan the QR code or click 👉 https://professional.diabetes.org/clinical-support/management-type-1-ada-easd-consensus-report

🚨 In case you missed it - we invite you to share your feedback! 📝

Last week at , Richard Holt and Anne Peters presented the updated European Association for the Study of Diabetes & American Diabetes Association consensus report on the management of type 1 diabetes in adults.

🔍 This update reflects the latest evidence and offers practical recommendations to help clinicians worldwide deliver optimal care for adults living with type 1 diabetes.

📢 The consensus report is now open for consultation! If you’d like to review the report and share your thoughts, simply scan the QR code or click 👉 https://professional.diabetes.org/clinical-support/management-type-1-ada-easd-consensus-report

07/10/2025

📢 Don’t miss the upcoming EASD Early Career Academy Webinar!

Title: High-resolution approaches to study white adipose tissue in health and cardiometabolic disease

🗓️14 October 2025 | 🕛17:00 CEST

Join Professors Niklas Mejhert and Mikael Rydén from the Karolinska Institutet as they explore how high-resolution spatial analyses of human white adipose tissue biopsies can uncover cellular organisation and deepen our understanding of adipose biology in health and cardiometabolic disease.

Register now to reserve your spot 🔗👉 https://us06web.zoom.us/webinar/register/WN_N0MEzQeVT5WxKb_MjHs8BA #/registration

06/10/2025

⏰ Applications closing soon! Join our team and work closely with the EASD Leadership to help drive our association forward!

✅ If you are organised, detail-oriented, an excellent communicator and able to manage multiple processes with ease, we encourage you to apply.

We look forward to receiving your application by 9 October 2025.

📅 Learn more and apply now:https://www.easd.org/uploads/JobAd_Executive-Assistant_2025_final.pdf

🌟 We’re Hiring: Executive Assistant 🌟

Join our passionate team and work closely with EASD leadership to help drive our association forward!

In this role, you will:
🗂️ Support the Board, Committees & leadership in administrative tasks
📅 Coordinate meetings, follow-ups, and keep our operations running smoothly
💡 Dive into new topics and contribute to the success of the organization

Are you:
✅ Highly organised & structured
✅ A strong communicator
✅ Able to juggle multiple processes with ease

If this sounds like you, we’d be delighted to receive your application by 9 October 2025.

📩 Learn more and apply now:https://www.easd.org/uploads/JobAd_Executive-Assistant_2025_final.pdf

02/10/2025

💥🎙️ New Podcast Episode: What does a lifetime of discovery look like in diabetes research?

In our latest episode, we speak with Prof. Andrew Hattersley (University of Exeter), recipient of the 57th EASD Claude Bernard Prize, about his groundbreaking work on genetic forms of diabetes, his global impact on neonatal diabetes care, and his vision for the future of precision medicine in type 2 diabetes.

🎧 Listen now 👉 https://www.easd.org/media-centre/podcasts.html

01/10/2025

🥁 New Diabetes Perspectives episode is out now on our first-ever EASD Guideline on the assessment and management of diabetes distress! Until the end of October, we invite you to provide feedback on the draft.

👉 The guideline development panel co-chairs Professors Jane Speight, Richard Holt and member Michelle Law presented the guideline draft just a few weeks ago at the EASD Annual Meeting. They’ve also sat down in our latest Diabetes Perspectives episode to break down the draft and what it means for healthcare providers:

✅ What is diabetes distress and how common is it in T1D and T2D?
✅ How might we assess it in routine care using evidence-based strategies?
✅ Which interventions reduce distress and for whom?
✅ Why haven’t AID trials shown overall reductions in distress yet?
✅ How can services adopt/adapt the guideline in their own context?

📺👉🏼 Watch the episode on the EASD e-Learning platform: https://easd-elearning.eu/episode/348/Decoding-the-EASD-Diabetes-Distress-Guideline.html

📖👉 Read the full guideline and give your feedback here: https://www.easd.org/guidelines/statements-guidelines/diabetes-distress/

01/10/2025

📢 The 2025 update of the Algorithm for Management of Adults with Dyslipidemia is now available!

An international multidisciplinary task force of clinical experts, including representatives from American Association of Clinical Endocrinology (AACE), the Canadian Cardiovascular Society, the Latin American Academy for the Study of Lipids and Cardiometabolic Risk and the European Association for the Study of Diabetes, released an updated consensus statement on the 2020 AACE algorithm for dyslipidemia.

We are pleased to highlight the contribution of Prof. Fredrik Karpe (University of Oxford) as EASD’s representative in this important collaboration.

🔗👉 Read the full consensus statement here: https://www.endocrinepractice.org/article/S1530-891X(25)00972-3/fulltext

The official published American Association of Clinical Endocrinology Consensus Statement: Algorithm for Management of Adults with Dyslipidemia – 2025 Update is now available! Read the algorithm: https://www.endocrinepractice.org/article/S1530-891X(25)00972-3/fulltext w/ Canadian Cardiovascular Society & European Association for the Study of Diabetes

30/09/2025

💡 Meet Dr. Frank Ning (Karolinska Institutet), recipient of the EFSD/Lilly Young Investigator Award. His project, “Targeting vascular endothelial growth factor B in adipose tissue as a strategy in combating diabetic cardiomyopathy (DCM),” investigates how vascular endothelial growth factor B (VEGFB) contributes to heart damage in type 2 diabetes.

🗣️ Dr. Ning reflects:
“Being a recipient of the EFSD/Lilly Young Investigator Award has been an invaluable experience. It provided crucial support to pursue high impact, translational research at an early stage of my career. The funding and recognition have significantly enhanced my scientific profile and helped lay the foundation for future research.”

📖 Read the paper: https://pubmed.ncbi.nlm.nih.gov/39689809
💡 Explore EFSD opportunities: https://www.europeandiabetesfoundation.org/programmes.html

Programme supported by Lilly Diabetes International